Precision staging of Type 2 diabetes through Hypergraph-Based multimorbidity Profiling: From hepatic disruption to cardiovascular escalation

Key Points

• Cardiovascular risk escalates as hepatic disruption intensifies in patients with type 2 diabetes, suggesting a critical relationship.
• Key evidence shows that multimorbidity profiling enhances the precision of diabetes staging through hypergraph approaches.
• This analysis employs hypergraph-based profiling techniques to identify risk factors and their interplay in type 2 diabetes populations.
• Results indicate the necessity for tailored treatment strategies in managing diabetes-related complications, emphasizing integrated care.